These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 3782801)

  • 21. Expression of the major surface glycoprotein of Leishmania donovani chagasi in virulent and attenuated promastigotes.
    Wilson ME; Hardin KK; Donelson JE
    J Immunol; 1989 Jul; 143(2):678-84. PubMed ID: 2738406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leishmania braziliensis: protein, carbohydrate, and antigen differences between log phase and stationary phase promastigotes in vitro.
    Grögl M; Franke ED; McGreevy PB; Kuhn RE
    Exp Parasitol; 1987 Jun; 63(3):352-9. PubMed ID: 3582573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
    Tonui WK; Titus RG
    Am J Trop Med Hyg; 2007 Mar; 76(3):579-84. PubMed ID: 17360887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Montenegro's skin reactions and antibodies against different Leishmania species in dogs from a visceral leishmaniosis endemic area.
    Baleeiro CO; Paranhos-Silva M; dos Santos JC; Oliveira GG; Nascimento EG; de Carvalho LP; dos-Santos WL
    Vet Parasitol; 2006 Jun; 139(1-3):21-8. PubMed ID: 16567046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcellular and taxonomic specificity of monoclonal antibodies to New World Leishmania.
    Anthony RL; Williams KM; Sacci JB; Rubin DC
    Am J Trop Med Hyg; 1985 Nov; 34(6):1085-94. PubMed ID: 2422966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Leishmania (Leishmania) tropica axenic amastigotes.
    Nasereddin A; Schweynoch C; Schonian G; Jaffe CL
    Acta Trop; 2010 Jan; 113(1):72-9. PubMed ID: 19782652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular amastigote-like forms of Leishmania panamensis and L. braziliensis. II. Stage- and species-specific monoclonal antibodies.
    Eperon S; McMahon-Pratt D
    J Protozool; 1989; 36(5):510-8. PubMed ID: 2478699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E; Lang T; Glaichenhaus N; Antoine JC
    J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
    de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
    Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The major surface protein of Leishmania promastigotes is a fibronectin-like molecule.
    Rizvi FS; Ouaissi MA; Marty B; Santoro F; Capron A
    Eur J Immunol; 1988 Mar; 18(3):473-6. PubMed ID: 2965651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface antigenic change during differentiation of a parasitic protozoan, Leishmania mexicana: Identification by monoclonal antibodies.
    Fong D; Chang KP
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7366-70. PubMed ID: 6961414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin enhances the interaction of infective Leishmania donovani promastigotes with mouse peritoneal macrophages. A fluorescence flow cytometric analysis.
    Butcher BA; Sklar LA; Seamer LC; Glew RH
    J Immunol; 1992 May; 148(9):2879-86. PubMed ID: 1573275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen-reactive gamma delta T cells in human leishmaniasis.
    Russo DM; Armitage RJ; Barral-Netto M; Barral A; Grabstein KH; Reed SG
    J Immunol; 1993 Oct; 151(7):3712-8. PubMed ID: 8376802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism.
    Ambrosio AR; De Messias-Reason IJ
    Parasite Immunol; 2005 Sep; 27(9):333-40. PubMed ID: 16149991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirements of defined cultivation conditions for standard growth of Leishmania promastigotes in vitro.
    Lemesre JL; Darcy F; Kweider M; Capron A; Santoro F
    Acta Trop; 1988 Jun; 45(2):99-108. PubMed ID: 2901211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Leishmania (Leishmania) amazonensis growth and infectivity by aureobasidin A.
    Tanaka AK; Valero VB; Takahashi HK; Straus AH
    J Antimicrob Chemother; 2007 Mar; 59(3):487-92. PubMed ID: 17242034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and purification of a 72 kDa antigen of Leishmania braziliensis braziliensis present on the surface and in the cytoplasm of the promastigotes and its specific recognition by sera from mucocutaneous leishmaniasis patients.
    Kutner S; Pellerin P; Brenière SF; Desjeux P; Dedet JP
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():431-4. PubMed ID: 3253506
    [No Abstract]   [Full Text] [Related]  

  • 38. Species and stage specificity of Leishmania donovani antigens.
    White AC; Hanham C
    J Parasitol; 1991 Feb; 77(1):142-50. PubMed ID: 1704058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies that react with Leishmania (Viannia) naiffi.
    Hanham CA; Shaw JJ; Lainson R
    J Parasitol; 1991 Oct; 77(5):680-7. PubMed ID: 1919913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth cycle-dependent generation of complement-resistant Leishmania promastigotes.
    Franke ED; McGreevy PB; Katz SP; Sacks DL
    J Immunol; 1985 Apr; 134(4):2713-8. PubMed ID: 3973390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.